Abstract
Ataxia telangiectasia mutated (ATM) is a key gene in DNA double-strand break (DSB), and therefore, most of its disabling genetic alterations play an important initiative role in many types of cancer. However, the exact role of ATM gene and its epigenetic alterations, especially promoter methylation in different grades of brain tumors, remains elusive. The current study was conducted to query possible correlations among methylation statue of ATM gene, ATM/ retinoblastoma (RB) protein expression, D1853N ATM polymorphism, telomere length (TL), and clinicopathological characteristics of various types of brain tumors. Isolated DNA from 30 fresh tissues was extracted from different types of brain tumors and two brain tissues from deceased normal healthy individuals. DNAs were treated with bisulfate sodium using DNA modification kit (Qiagen). Methylation-specific polymerase chain reaction (MSP-PCR) was implicated to determine the methylation status of treated DNA templates confirmed by promoter sequencing. Besides, the ATM and RB protein levels were determined by immunofluorescence (IF) assay using monoclonal mouse antihuman against ATM, P53, and RB proteins. To achieve an interactive correlation, the methylation data were statistically analyzed by considering TL and D1853N ATM polymorphism. More than 73 % of the brain tumors were methylated in ATM gene promoter. There was strong correlation between ATM promoter methylation and its protein expression (p < 0.001). As a triangle, meaningful correlation was also found between methylated ATM promoter and ATM protein expression with D1853N ATM polymorphism (p = 0.01). ATM protein expression was not in line with RB protein expression while it was found to be significantly correlated with ATM promoter methylation (p = 0.01). There was significant correlation between TL neither with ATM promoter methylation nor with ATM protein expression nor with D1853N polymorphism. However, TL has shown strong correlation with patient’s age and tumor grade (p = 0.01). Given the important role of cell cycle checkpoint proteins as well as RB and ATM in TL and cancer evolution, further assessment is warranted to shed more light on the pathway linking the telomere instability to tumor progression. High ATM methylation rate in brain tumor patients could open a new avenue toward early screening and cancer therapy.
Similar content being viewed by others
References
Lavin MF, Birrell G, Chen P, Kozlov S, Scott S, Gueven N (2005) ATM signaling and genomic stability in response to DNA damage. Mutat Res 569:123–132
Jazayeri A, Falck J, Lukas C, Bartek J, Smith GC, Lukas J, Jackson SP (2006) ATM-and cell cycle-dependent regulation of ATR in response to DNA double-strand breaks. Nat Cell Biol 8:37–45
Oliver AW, Knapp S, Pearl LH (2007) Activation segment exchange: a common mechanism of kinase autophosphorylation? Trends Biochem Sci 32:351–356
Berkovich E, Ginsberg D (2003) ATM is a target for positive regulation by E2F-1. Oncogene 22:161–167
Lin WC, Lin FT, Nevins JR (2001) Selective induction of E2F1 in response to DNA damage, mediated by ATM-dependent phosphorylation. Genes Dev 15:1833–1844
Bartkova J, Rezaei N, Liontos M, Karakaidos P, Kletsas D, Issaeva N, Vassiliou LV, Kolettas E, Niforou K, Zoumpourlis VC, Takaoka M, Nakagawa H, Tort F, Fugger K, Johansson F, Sehested M, Andersen CL, Dyrskjot L, Orntoft T, Lukas J, Kittas C, Helleday T, Halazonetis TD, Bartek J, Gorgoulis VG (2006) Oncogene-induced senescence is part of the tumorigenesis barrier imposed by DNA damage checkpoints. Nature 444:633–637
Liang Y, Lin SY, Brunicardi FC, Goss J, Li K (2009) DNA damage response pathways in tumor suppression and cancer treatment. World J Surg 33:661–666
Ye C, Cai Q, Dai Q, Shu XO, Shin A, Gao YT, Zheng W (2007) Expression patterns of the ATM gene in mammary tissues and their associations with breast cancer survival. Cancer 109:1729–1735
Chiu YT, Liu J, Tang K, Wong YC, Khanna KK, Ling MT (2012) Inactivation of ATM/ATR DNA damage checkpoint promotes androgen induced chromosomal instability in prostate epithelial cells. PLoS One 7:e51108
Ye J, Qi Y, Wang W, Sun F, Wei Q, Su T, Zhou W, Jiang Y, Yuan W, Cai J, Cui B, Ning G (2012) Lower expression of ATM and gene deletion is more frequent in adrenocortical carcinomas than adrenocortical adenomas. Endocrine 41:479–486
Kim JW, Im SA, Kim MA, Cho HJ, Lee DW, Lee KH, Kim TY, Han SW, Oh DY, Lee HJ, Yang HK, Kim WH, Bang YJ (2013) Ataxia-telangiectasia-mutated protein expression with microsatellite instability in gastric cancer as prognostic marker. Int J Cancer 134:72–80
Wu CW, Dong YJ, Liang QY, He XQ, Ng SS, Chan FK, Sung JJ, Yu J (2013) MicroRNA-18a attenuates DNA damage repair through suppressing the expression of ataxia telangiectasia mutated in colorectal cancer. PLoS One 8:e57036
Morgan WF, Corcoran J, Hartmann A, Kaplan MI, Limoli CL, Ponnaiya B (1998) DNA double-strand breaks, chromosomal rearrangements, and genomic instability. Mutat Res 404:125–128
Sinha S, Ghildiyal R, Mehta VS, Sen E (2013) ATM-NFkappaB axis-driven TIGAR regulates sensitivity of glioma cells to radiomimetics in the presence of TNFalpha. Cell Death Dis 4:e615
Kheirollahi M, Mehr-Azin M, Kamalian N, Mehdipour P (2011) Expression of cyclin D2, P53, Rb and ATM cell cycle genes in brain tumors. Med Oncol 28:7–14
Liberzon E, Avigada S, Cohen IJ, Yaniv I, Michovitz SH, Zaizov R (2003) ATM gene mutations are not involved in medulloblastoma in children. Cytogenet 146:167–169
Mehdipour P, Mahdavi M, Mohammadi-Asl J, Atri M (2011) Importance of ATM gene as a susceptible trait: predisposition role of D1853N polymorphism in breast cancer. Med Oncol 28:733–737
Mehdipour P, Habibi L, Mohammadi-Asl J, Kamalian N, Mehr Azin M (2008) Three-hit hypothesis in astrocytoma: tracing the polymorphism D1853N in ATM gene through a pedigree of the proband affected with primary brain tumor. J Cancer Res Clin Oncol 134:1173–1180
Muraki K, Han L, Miller D, Murnane JP (2013) The role of ATM in the deficiency in nonhomologous end-joining near telomeres in a human cancer cell line. PLoS Genet 9:e1003386
Kim WJ, Vo QN, Shrivastav M, Lataxes TA, Brown KD (2002) Aberrant methylation of the ATM promoter correlates with increased radiosensitivity in a human colorectal tumor cell line. Oncogene 21:3864–3871
Ai L, Vo QN, Zuo C, Li L, Ling W, Suen JY, Hanna E, Brown KD, Fan CY (2004) Ataxia-telangiectasiamutated (ATM) gene in head and neck squamous cell carcinoma: promoter hypermethylation with clinical correlation in 100 cases. Cancer Epidemiol Biomarkers Prev 13:150–156
Vo QN, Kim WJ, Cvitanovic L, Boudreau DA, Ginzinger DG, Brown KD (2004) The ATM gene is a target for epigenetic silencing in locally advanced breast cancer. Oncogene 23:9432–9437
Roy K, Wang L, Makrigiorgos GM, Price BD (2006) Methylation of the ATM promoter in glioma cells alters ionizing radiation sensitivity. Biochem Biophys Res Commun 344:821–826
Safar AM, Spencer H, Su X, Cooney CA, Shwaiki A, Fan CY (2007) Promoter hypermethylation for molecular nodal staging in non-small cell lung cancer. Arch Pathol Lab Med 131:936–941
Flanagan JM, Wilhelm-Benartzi CS, Metcalf M, Kaye SB, Brown R (2013) Association of somatic DNA methylation variability with progression-free survival and toxicity in ovarian cancer patients. Ann Oncol 24:2813–2818
Bhattacharya N, Mukherjee N, Singh R, Sinha S, Alam N, Roy A, Roychoudhury S, Panda C (2012) Frequent alterations of MCPH1 and ATM are associated with primary breast carcinoma: clinical and prognostic implications. Ann Surg Oncol:1–9
Kheirollahi M, Mehrazin M, Kamalian N, Mehdipour P (2010) Alterations of telomere length in human brain tumors. Med Oncol 28:864–870
Kanoh J, Francesconi S, Collura A, Schramke V, Ishikawa F, Baldacci G, Geli V (2003) The fission yeast spSet1p is a histone H3-K4 methyltransferase that functions in telomere maintenance and DNA repair in an ATM kinase Rad3-dependent pathway. J Mol Biol 326:1081–1094
Treilleux I, Chapot B, Goddard S, Pisani P, Angele S, Hall J (2007) The molecular causes of low ATM protein expression in breast carcinoma; promoter methylation and levels of the catalytic subunit of DNA-dependent protein kinase. Histopathology 51:63–69
Tapia T, Sanchez A, Vallejos M, Alvarez C, Moraga M, Smalley S, Camus M, Alvarez M, Carvallo P (2008) ATM allelic variants associated to hereditary breast cancer in 94 Chilean women: susceptibility or ethnic influences? Breast Cancer Res Treat 107:281–288
Meier M, den Boer ML, Hall AG, Irving JA, Passier M, Minto L, van Wering ER, Janka-Schaub GE, Pieters R (2005) Relation between genetic variants of the ataxia telangiectasia-mutated (ATM) gene, drug resistance, clinical outcome and predisposition to childhood T-lineage acute lymphoblastic leukaemia. Leukemia 19:1887–1895
Kim S, Parks CG, Xu Z, Carswell G, DeRoo LA, Sandler DP, Taylor JA (2012) Association between genetic variants in DNA and histone methylation and telomere length. PLoS One 7:e40504
Silva E, Tiong S, Pedersen M, Homola E, Royou A, Fasulo B, Siriaco G, Campbell SD (2004) ATM is required for telomere maintenance and chromosome stability during Drosophila development. Curr Biol 14:1341–1347
Gonzalo S, Garcia-Cao M, Fraga MF, Schotta G, Peters AH, Cotter SE, Eguia R, Dean DC, Esteller M, Jenuwein T, Blasco MA (2005) Role of the RB1 family in stabilizing histone methylation at constitutive heterochromatin. Nat Cell Biol 7:420–428
Garcia-Cao M, Gonzalo S, Dean D, Blasco MA (2002) A role for the Rb family of proteins in controlling telomere length. Nat Genet 32:415–419
Blackburn E (2001) Switching and signaling at the telomere. Cell 106:661–673
Artandi SE, DePinho RA (2010) Telomeres and telomerase in cancer. Carcinogenesis 31:9–18
Lee S, Donehower LA, Herron AJ, Moore DD, Fu L (2010) Disrupting circadian homeostasis of sympathetic signaling promotes tumor development in mice. PLoS 10
Acknowledgments
This is to acknowledge the surgery and nursery teams in Shariati hospital and also the patients for their support.
Conflict of Interest
There is no commercial/financial conflict of interest among all of the authors of this article.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Mehdipour, P., Karami, F., Javan, F. et al. Linking ATM Promoter Methylation to Cell Cycle Protein Expression in Brain Tumor Patients: Cellular Molecular Triangle Correlation in ATM Territory. Mol Neurobiol 52, 293–302 (2015). https://doi.org/10.1007/s12035-014-8864-9
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12035-014-8864-9